益肾活血解毒方联合揿针治疗肾虚血瘀型多发性骨髓瘤患者周围神经病变的临床效果

doi:10.20047/j.issn1673-7210.2023.19.32

Abstract
Figure/Table
References (31)
Related Citation (15)

Download: PDF (942 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Yishen Huoxue Jiedu Decoction combined with press-needle on peripheral neuropathy in patients with multiple myeloma of kidney deficiency and blood stasis type. Methods A total of 80 peripheral neuropathy patients with multiple myeloma of kidney deficiency and blood stasis type in Langfang Traditional Chinese Medicine Hospital of Hebei Province from October 2019 to August 2022 were selected and divided into control group and study group according to random number table method, with 40 cases in each group. The control group was given the western medicine Mecobalamin and Folic acid nutritional nerve treatment, and the study group was treated with Yishen Huoxue Jiedu Decoction combined with press-needle on the basis of oral nutritional nerve treatment. Both groups were treated for two courses. The improvement of peripheral neuropathy grading, immune function, quality of life (Karnofsky performance status [KPS], pain degree numerical rating scale [NRS], Pittsburgh sleep quality index scale [PSQI], Hamilton anxiety scale [HAMA]), and traditional Chinese medicine symptom score of the two groups were compared before and after treatment. Results After treatment, the grade of peripheral neuropathy in the two groups was better than before treatment, and the study group was better than the control group (P＜0.05). After treatment, CD4+ and CD4+/CD8+ in the study group were higher than before treatment, and those in the study group were higher than those in the control group (P＜0.05). CD8+ in the study group was lower than that before treatment, and that in the study group was lower than that in the control group (P＜0.05). After treatment, the KPS score of the two groups was higher than before treatment, and that of the study group was higher than that of the control group (P＜0.05). NRS, PSQI, and HAMA scores of the two groups were lower than before treatment, and those of the study group were lower than those of the control group (P＜0.05). After treatment, the scores of hand and foot numbness, sensory disturbance, limb pain, and cold aggravation in both groups were lower than before treatment, and those in the study group were lower than those in the control group (P＜0.05). Conclusion Yishen Huoxue Jiedu Decoction combined with press-needle has good clinical efficacy on peripheral neuropathy in patients with multiple myeloma of kidney deficiency and blood stasis type, improving peripheral neuropathy, regulating immune function, improving sleep quality and anxiety, and improving patients’ quality of life.

Key words： Press-needle Multiple myeloma Yishen Huoxue Jiedu Decoction Peripheral neuropathy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GAO Erchao LI Yingqiao PANG Hongcui ZHOU Zhenhuan WANG Maosheng

Cite this article:

GAO Erchao LI Yingqiao PANG Hongcui ZHOU Zhenhuan WANG Maosheng. Clinical effect of Yishen Huoxue Jiedu Decoction combined with press-needle on peripheral neuropathy in patients with multiple myeloma of kidney deficiency and blood stasis type[J]. 中国医药导报, 2023, 20(19): 143-148.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.19.32 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I19/143

[1] Wang S，Xu L，Feng J，et al. Prevalence and Incidence of Multiple Myeloma in Urban Area in China： A National Population-Based Analysis [J]. Front Oncol，2020，9：1513.
[2] 中国医师协会血液科医师分会多发性骨髓瘤专业委员会.多发性骨髓瘤周围神经病变诊疗中国专家共识（2015年）[J].中华内科杂志，2015，54（9）：821-824.
[3] 曹亚峰，王静，顾俊，等.以硼替佐米为基础的联合方案治疗114例初诊多发性骨髓瘤患者的周围神经病变分析[J].诊断学理论与实践，2017，16（5）：492-497.
[4] 李晓茵，蔡骅，叶晖蓉，等.心理弹性在多发性骨髓瘤患者预期性悲伤与应对方式间的中介效应[J].中国医药导报，2022，19（27）：170-173，193.
[5] 杨淑莲，王茂生.血液病中医治验心悟[M].北京：人民军医出版社，2014：67-75.
[6] 李迎巧，高二超，王茂生.杨淑莲治疗多发性骨髓瘤经验[J].陕西中医，2022，43（5）：628-631，652.
[7] 中国医师协会血液科医师分会，中华医学会血液学分会，中国医师协会多发性骨髓瘤专业委员会.中国多发性骨髓瘤诊治指南（2020年修订）[J].中华内科杂志，2020，59（5）：341-346.
[8] 郑筱萸.中药新药临床研究指导原则（试行）[M].北京：中国医药科技出版社，2002：383-388.
[9] 沈悌，赵永强.血液病诊断及疗效标准[M].4版.北京：科学出版社，2018：290-294.
[10] 皋文君，刘砚燕，袁长蓉.国际肿瘤化疗药物不良反应评价系统——通用不良反应术语标准4.0版[J].肿瘤，2012，32（2）：142-144.
[11] 体能状态评分ECOG评分法[J].中华普通外科学文献（电子版），2012，6（6）：556.
[12] Mehta A，Chai E，Berglund K，et al. Using Admission Karnofsky Performance Status as a Guide for Palliative Care Discharge Needs [J]. J Palliat Med，2021，24（6）：910-913.
[13] 李春蕊，张雯，樊碧发.数字评分法（NRS）与口述评分法（VRS）在老年慢性疼痛患者中的比较[J].中国疼痛医学杂志，2016，22（9）：683-686.
[14] 刘志喜，石倩萍，杨洪霞，等.匹兹堡睡眠质量指数量表在护理人群中的信效度评价[J].汕头大学医学院学报，2020，33（3）：173-176.
[15] 侍成栋，潘永良.汉密尔顿抑郁及焦虑量表与正性负性情绪量表的相关性研究[J].全科护理，2019，17（2）：140- 142.
[16] 陈文明，徐瑞荣.多发性骨髓瘤中西医结合诊疗专家共识（2019）[J].中华医学杂志，2019，99（28）：2169-2175.
[17] 路瑾.多发性骨髓瘤诊治进展[J].山东大学学报，2019， 57（7）：12-15.
[18] 余海青，李敏婕，郑美芳.甲钴胺对硼替佐米所致多发性骨髓瘤患者周围神经病变的防治效果[J].新乡医学院学报，2018，35（7）：620-622.
[19] 徐海萍，陈文宇，徐龙生，等.中药足浴在预防硼替佐米引起的急性周围神经病变中的疗效观察[J].中国现代医生，2019，57（24）：93-96.
[20] 余莹，程健，李海潮.中医综合疗法阶梯式治疗多发性骨髓瘤周围神经病变的临床疗效[J].山东中医杂志，2018，37（5）：381-384.
[21] 齐绩，戴铁颖，葛杭萍，等.硼替佐米致周围神经病变的中医证型分布规律探讨[J].浙江中医杂志，2019，54（2）：141-142.
[22] 周艳群，林玲云，陈本澍，等.基于网络药理学与分子对接技术探讨补肾活血方治疗多发性骨髓瘤的物质基础与作用机制[J].中国医药导报，2021，18（25）：119-123， 198.
[23] 李宜真，李慧.补肾活血法联合硼替佐米治疗多发性骨髓瘤的临床效果[J].中国医药科学，2021，11（15）：234- 236.
[24] 孙敬宣，侯佑柱，马凯，等.国医大师李士懋常用虫类药应用经验[J].中华中医药杂志，2021，36（8）：4697-4700.
[25] 梁芳妮，马燕辉，刘红玉，等.揿针主要临床应用研究进展[J].中医药导报，2019，25（11）：126-128.
[26] 李华华，岳姣姣，刘怀民，等.化嗝颗粒联合耳穴埋揿针在食管癌术后化疗的运用及对失眠焦虑的影响[J].中医研究，2022，35（7）：16-20.
[27] 王玲姝，李冠男，李静.穴位埋线联合揿针耳穴贴压治疗心脾两虚型失眠症及对生活质量影响[J].辽宁中医药大学学报，2020，22（4）：28-31.
[28] 芮明忠，王子妍，芦茜.硼替佐米联合地塞米松治疗老年多发性骨髓瘤的临床效果及对血小板生成素和免疫细胞水平的影响[J].中国当代医药，2021，28（22）：55-58.
[29] 严志民，刘彦权，黄走方，等.T细胞亚群与细胞因子水平变化在多发性骨髓瘤患者临床诊疗及预后评估中的价值[J].中国实验血液学杂志，2022，30（6）：1791-1796.
[30] 巢玲，谢璟，徐烨，等.中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值对三药联合方案初始治疗多发性骨髓瘤患者无进展生存时间的预测价值[J].中国当代医药，2022，29（20）：156-160.
[31] 何江华，赵瑞.中医综合疗法改善多发性骨髓瘤周围神经病变患者神经功能的疗效观察[J].承德医学院学报，2021，38（5）：406-409.